Role of alveolar macrophages in chronic obstructive pulmonary disease

Frontiers in Immunology

Volumn 5, Issue SEP, 2014, Pages

  Vlahos, Ross ^a   Bozinovski, Steven ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alveolar macrophage; Chronic obstructive pulmonary disease; Efferocytosis; Lung inflammation; Oxidative stress; Resolution

Indexed keywords

CD163 ANTIGEN; CHEMOKINE RECEPTOR; CIGARETTE SMOKE; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IRRITANT AGENT; METALLOPROTEINASE; TRANSCRIPTOME;

APOPTOSIS; CELL PROLIFERATION; CELL RENEWAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; EMPHYSEMA; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MICROENVIRONMENT; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; REVIEW; STREPTOCOCCUS PNEUMONIA; TISSUE INJURY; WOUND HEALING;

EID: 84919416051     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00435     Document Type: Review

References (91)

1. van oud Alblas AB, van Furth R. Origin, kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med (1979) 149(6):1504-18. doi: 10.1084/jem.149.6.1504.
2. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 192(4243):1016-8. doi:10.1126/science.775638.
3. Guilliams M, De Kleer I, Henri S, Post S, Vanhoutte L, De Prijck S, et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med (2013) 210(10):1977-92. doi:10.1084/jem.20131199.
4. Maus UA, Janzen S, Wall G, Srivastava M, Blackwell TS, Christman JW, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol (2006) 35(2):227-35. doi:10.1165/rcmb.2005-0241OC.
5. Tarling JD, Lin HS, Hsu S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol (1987) 42(5):443-6.
6. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 38(4):792-804. doi:10.1016/j.immuni.2013.04.004.
7. Lin HS, Lokeshwar BL, Hsu S. Both granulocyte-macrophage CSF and macrophage CSF control the proliferation and survival of the same subset of alveolar macrophages. J Immunol (1989) 142(2):515-9.
8. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 15(4):557-67. doi:10.1016/S1074-7613(01)00218-7.
9. Franke-Ullmann G, Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes ML, Kobzik L. Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J Immunol (1996) 157(7):3097-104.
10. Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med (1989) 170(2):499-509. doi:10.1084/jem.170.2.499.
11. Prokhorova S, Lavnikova N, Laskin DL. Functional characterization of interstitial macrophages and subpopulations of alveolar macrophages from rat lung. J Leukoc Biol (1994) 55(2):141-6.
12. Holt PG. Inhibitory activity of unstimulated alveolar macrophages on T-lymphocyte blastogenic response. Am Rev Respir Dis (1978) 118(4):791-3.
13. Hoidal JR, Schmeling D, Peterson PK. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis (1981) 144(1):61-71. doi:10.1093/infdis/144.1.61.
14. Blumenthal RL, Campbell DE, Hwang P, DeKruyff RH, Frankel LR, Umetsu DT. Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol (2001) 107(2):258-64. doi:10.1067/mai.2001.112845.
15. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature (2003) 422(6928):169-73. doi:10.1038/nature01413.
16. Takabayshi K, Corr M, Hayashi T, Redecke V, Beck L, Guiney D, et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity (2006) 24(4):475-87. doi:10.1016/j.immuni.2006.02.008.
17. Coleman MM, Ruane D, Moran B, Dunne PJ, Keane J, Mills KH. Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells. Am J Respir Cell Mol Biol (2013) 48(6):773-80. doi:10.1165/rcmb.2012-0263OC.
18. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, Hibbs ML. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol (2012) 189(2):946-55. doi:10.4049/jimmunol.1200660.
19. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19(1):71-82. doi:10.1016/S1074-7613(03)00174-2.
20. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 23:901-44. doi:10.1146/annurev.immunol.23.021704.115816.
21. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 3(1):65-70. doi:10.1016/0952-7915(91)90079-G.
22. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol (1982) 107(3):395-418.
23. Hickman-Davis JM, O'Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, et al. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2002) 282:L944-56. doi:10.1152/ajplung.00216.2001.
24. Hashimoto S, Pittet JF, Hong K, Folkesson H, Bagby G, Kobzik L, et al. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am J Physiol (1996) 270(5 Pt 1):L819-28.
25. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L, et al. Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung Cell Mol Physiol (2002) 282(6):L1245-52. doi:10.1152/ajplung.00453.2001.
26. Dhaliwal K, Scholefield E, Ferenbach D, Gibbons M, Duffin R, Dorward DA, et al. Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury. Am J Respir Crit Care Med (2012) 186(6):514-24. doi:10.1164/rccm.201112-2132OC.
27. Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer RC. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res (2005) 6:61. doi:10.1186/1465-9921-6-61.
28. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, et al. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med (2003) 167(2):171-9. doi:10.1164/rccm.200207-698OC.
29. Cox G, Crossley J, Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol (1995) 12(2):232-7. doi:10.1165/ajrcmb.12.2.7865221.
30. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 101(4):890-8. doi:10.1172/JCI1112.
31. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol (2010) 84(15):7569-80. doi:10.1128/JVI.00291-10.
32. Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol (2013) 191(3):1250-9. doi:10.4049/jimmunol.1300014.
33. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med (2008) 14(5):558-64. doi:10.1038/nm1765.
34. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, et al. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med (2004) 200(2):267-72. doi:10.1084/jem.20040731.
35. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med (1998) 4(11):1241-3. doi:10.1038/3218.
36. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 22(4):672-88. doi:10.1183/09031936.03.00040703.
37. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G. Woodsmoke exposure and risk for obstructive airways disease among women. Chest (1996) 109(1):115-9. doi:10.1378/chest.109.1.115.
38. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med (2001) 163(5):1256-76. doi:10.1164/ajrccm.163.5.2101039.
39. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 160(5 Pt 2):S29-32. doi:10.1164/ajrccm.160.supplement_1.9.
40. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J (1998) 12(2):380-6. doi:10.1183/09031936.98.12020380.
41. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 153(2):530-4. doi:10.1164/ajrccm.153.2.8564092.
42. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med (2001) 164(3):469-73. doi:10.1164/ajrccm.164.3.2007149.
43. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 158(4):1277-85. doi:10.1164/ajrccm.158.4.9802078.
44. Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol (2013) 131(3):752-62. doi:10.1016/j.jaci.2012.11.053.
45. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 156(1):240-7. doi:10.1164/ajrccm.156.1.9612018.
46. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invets (1998) 78(9):1077-87.
47. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med (2000) 162(4 Pt 1):1355-60. doi:10.1164/ajrccm.162.4.9910097.
48. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2002) 26(5):602-9. doi:10.1165/ajrcmb.26.5.4685.
49. Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 152(4 Pt 1):1316-20. doi:10.1164/ajrccm.152.4.7551388.
50. Pela R, Marchesani F, Agostinelli C, Staccioli D, Cecarini L, Bassotti C, et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis (1998) 53(3):262-7.
51. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2006) 173(10):1114-21. doi:10.1164/rccm.200506-859OC.
52. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 363(12):1128-38. doi:10.1056/NEJMoa0909883.
53. Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol (2008) 214(1):27-37. doi:10.1002/jcp.21158.
54. Muller T, Gebel S. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis (1998) 19(5):797-801. doi:10.1093/carcin/19.5.797.
55. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J (2000) 16(3):534-54. doi:10.1034/j.1399-3003.2000.016003534.x.
56. Marti-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, Sauleda J, et al. Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun (2009) 77(10):4232-42. doi:10.1128/IAI.00305-09.
57. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2007) 37(6):748-55. doi:10.1165/rcmb.2007-0025OC.
58. Hodge S, Matthews G, Mukaro V, Ahern J, Shivam A, Hodge G, et al. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am J Respir Cell Mol Biol (2011) 44(5):673-81. doi:10.1165/rcmb.2009-0459OC.
59. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med (2009) 179(11):1011-21. doi:10.1164/rccm.200807-1148OC.
60. Minemetsu N, Blumental-Perry A, Shapiro SD. Cigarette smoke inhibits engulfment of apoptotic cells by macrophages through inhibition of actin rearrangement. Am J Respir Cell Mol Biol (2011) 44(4):474-82. doi:10.1165/rcmb.2009-0463OC.
61. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, et al. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest (1986) 78(2):482-93. doi:10.1172/JCI112600.
62. Shao MX, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol (2005) 175(6):4009-16. doi:10.4049/jimmunol.175.6.4009.
63. Liu K, Gualano RC, Hibbs ML, Anderson GP, Bozinovski S. Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection. J Biol Chem (2008) 283(15):9977-85. doi:10.1074/jbc.M710257200.
64. Banan A, Zhang Y, Losurdo J, Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut (2000) 46(6):830-7. doi:10.1136/gut.46.6.830.
65. Smerjac SM, Bizzozero OA. Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis. J Neurochem (2008) 105(3):763-72. doi:10.1111/j.1471-4159.2007.05178.x.
66. Bozinovski S, Vlahos R, Zhang Y, Lah LC, Seow HJ, Mansell A, et al. Carbonylation caused by cigarette smoke extract is associated with defective macrophage immunity. Am J Respir Cell Mol Biol (2011) 45(2):229-36. doi:10.1165/rcmb.2010-0272OC.
67. Kirkham PA, Spooner G, Rahman I, Rossi AG. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun (2004) 318(1):32-7. doi:10.1016/j.bbrc.2004.04.003.
68. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD (2004) 1(1):59-70. doi:10.1081/COPD-120028701.
69. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8(12):958-69. doi:10.1038/nri2448.
70. Agusti AG, Villaverde JM, Togores B, Bosch M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J (1999) 14(3):523-8. doi:10.1034/j.1399-3003.1999.14d34.x.
71. Bhowmik A, Seemungal TA, Donaldson GC, Wedzicha JA. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J (2005) 26(6):1009-15. doi:10.1183/09031936.05.00047305.
72. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 157(3 Pt 1):998-1002. doi:10.1164/ajrccm.157.3.97-05009.
73. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol (2008) 378(2):171-84. doi:10.1007/s00210-008-0286-7.
74. Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Muller T. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol Sci (2006) 93(2):422-31. doi:10.1093/toxsci/kfl071.
75. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med (2000) 162(2 Pt 1):701-6. doi:10.1164/ajrccm.162.2.9908132.
76. Mills CD, Ley K. M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 6(6). doi:10.1159/000364945.
77. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med (2005) 172(11):1383-92. doi:10.1164/rccm.200505-686OC.
78. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol (2009) 183(4):2867-83. doi:10.4049/jimmunol.0900473.
79. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164(12):6166-73. doi:10.4049/jimmunol.164.12.6166.
80. Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol (2012) 32(6):463-88. doi:10.1615/CritRevImmunol.v32.i6.10.
81. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 25(12):677-86. doi:10.1016/j.it.2004.09.015.
82. Van Gorp H, Delputte PL, Nauwynck HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol (2010) 47(7-8):1650-60. doi:10.1016/j.molimm.2010.02.008.
83. Kunz LI, Lapperre TS, Snoeck-Stroband JB, Budulac SE, Timens W, van Wijngaarden S, et al. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res (2011) 12:34. doi:10.1186/1465-9921-12-34.
84. Dolinay T, Choi AM, Ryter SW. Heme oxygenase-1/CO as protective mediators in cigarette smoke-induced lung cell injury and chronic obstructive pulmonary disease. Curr Pharm Biotechnol (2012) 13(6):769-76. doi:10.2174/138920112800399338.
85. Williams L, Jarai G, Smith A, Finan P. IL-10 expression profiling in human monocytes. J Leukoc Biol (2002) 72(4):800-9.
86. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J (1999) 14(2):309-14. doi:10.1183/09031936.99.14230999.
87. Anthony D, McQualter JL, Bishara M, Lim EX, Yatmaz S, Seow HJ, et al. SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling. FASEB J (2014). doi:10.1096/fj.14-250332.
88. Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, Merritt AS, et al. Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2012) 109(3):935-40. doi:10.1073/pnas.1109382109.
89. Bozinovski S, Anthony D, Anderson GP, Irving LB, Levy BD, Vlahos R. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways. Pharmacol Ther (2013) 140(3):280-9. doi:10.1016/j.pharmthera.2013.07.007.
90. El Kebir D, Jozsef L, Khreiss T, Pan W, Petasis NA, Serhan CN, et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol (2007) 179(1):616-22. doi:10.4049/jimmunol.179.1.616.
91. Anthony D, Seow HJ, Uddin M, Thompson M, Dousha L, Vlahos R, et al. Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and gammadelta T cells. Am J Respir Crit Care Med (2013) 188(2):179-86. doi:10.1164/rccm.201211-2139OC.